Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Stage III Kidney Wilms Tumor: later-stage trial registry

1 of 4 indexed Stage III Kidney Wilms Tumor trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Stage III Kidney Wilms Tumor: 4 US clinical trials tracked, 1 recruiting.

Stage III Kidney Wilms Tumor is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Oncology Group, running 4 of these trials.

Enrollment posture brief

Registry condition stage-iii-kidney-wilms-tumor

OPEN 1 | RECR 25% | LATE 3 | EARLY 1 | RANK #4115 | SPON 4

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Stage III Kidney Wilms T (th…25%
Open-enrollment share among volume-matched conditions near Stage III Kidney Wilms Tumor

Stage III Kidney Wilms Tumor lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stage III Kidney Wilms Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stage III Kidney Wilms Tumor is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 33

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 3

Top Sponsors

Named interventions

Most-linked intervention names on Stage III Kidney Wilms Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Dactinomycin Biological
3 trials
3-Dimensional Conformal Radiation Therapy Radiation
2 trials
Doxorubicin Hydrochloride Drug
2 trials
Computed Tomography Procedure
2 trials
Biospecimen Collection Procedure
2 trials
Vincristine Sulfate Drug
1 trials
Conventional Surgery Procedure
1 trials
Therapeutic Conventional Surgery Procedure
1 trials

US sites by state

Facility locations filed on Stage III Kidney Wilms Tumor trials. A trial with sites in several states counts in each.

California 4 trials
Arizona 4 trials
Arkansas 4 trials
Alabama 4 trials
Colorado 1 trials
Alaska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Stage III Kidney Wilms Tumor page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage III Kidney Wilms Tumor condition card totals 4 registered trials; most-linked intervention Dactinomycin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.